When should we use parenteral methotrexate? Oral methotrexate is the benchmark against which other disease-modifying anti rheumatic drugs are measured. The use of parenteral methotrexate for those failing to tolerate or respond to oral therapy is accepted, but indications for its use and its place in the therapeutic ladder have not been fully investigated. Hayley Mainman. Clinical Rheumatology. 06/11/10. (Also see: Medications)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
When should we use parenteral methotrexate?
No replies to this topic